2024年

業績目録

原著

  1. Copper-mediated astatination of 211At-labelled prostate-specific membrane antigen probes in the presence of basic salts. Shigeki Watanabe, Yuto Kondo, Ichiro Sasaki, Yasuhiro Ohshima, Hiroyuki Kimura*, and Noriko S. Ishioka. Tetrahedron Letters in press
  2. Host-to-graft propagation of inoculated α-synuclein into transplanted human induced pluripotent stem cell-derived midbrain dopaminergic neurons. Serina Gima, Kazuya Oe, Kaneyasu Nishimura, Takashi Ohgita, Haruka Ito, Hiroyuki Kimura, Hiroyuki Saito and Kazuyuki Takata. Regenerative Therapy, 25, 229-237 (2024)
  3. One-pot two-step radioiodination based on copper-mediated iododeboronation and azide–alkyne cycloaddition reaction. Yuto Kondo, Hiroyuki Kimura*, Ryota Chisaka, Yasunao Hattori, Hidekazu Kawashima and Hiroyuki Yasui. Chemical Communications, 60, 714-717 (2024)
  4. Production and synthesis of a novel 191Pt-labeled platinum complex and evaluation of its biodistribution in healthy mice. Marina Omokawa, Hiroyuki Kimura*, Yuichi Hatsukawa, Hidekazu Kawashima, Kazuaki Tsukada, Yusuke Yagi, Yuki Naito and Hiroyuki Yasui. Bioorganic & Medicinal Chemistry, 97, 117557 (2024), 10.1016/j.bmc.2023.117557
  5. Synthesis and biological evaluation of a novel sugar-conjugated platinum(Ⅱ) complex having a tumor-targeting effect. Marina Omokawa, Hiroyuki Kimura*, Kenji Arimitsu, Yusuke Yagi, Yasunao Hattori, Hidekazu Kawashima, Yuki Naito, Hiroyuki Yasui. ACS Omega, 879-886 (2024)

国際及び国内学会発表

  1. 小阪孝史, 北村陽二, 小川数馬, 木村寛之.(ポスター), 新規σ-2受容体リガンドMILVの開発とイメージング剤としての基礎評価.日本薬学会 第144年会(横浜),2024年3月30日.

シンポジウム、ワークショップ及び講演

  1. 木村寛之.(講演・口頭):「Development of theranostics probes targeting erythropoietin-producing hepatocellular A2 receptor expressed in cancer」. 日本薬学会第144年会・一般シンポジウムS01・Imaging is amazing!-All imaging leads to therapy(横浜,パシフィコ横浜), 2024.0329.米持 悦生
  2. 木村寛之.(講演・口頭):「多様なRIを利用した放射性医薬品開発と自動合成システム」. 放射線取扱技術研修会/北陸地域アイソトープ研究会第26回総会(金沢,金沢ニューグランドホテル), 2024.0311. 横山 明彦
page top